The Helmholtz Centre for Infection Research (HZI) is organised in the form of a GmbH (equals “Ltd.”). Shareholders are the Federal Republic of Germany (90 percent) and the federal states Lower-Saxony (nine percent) and Saarland (one percent).
Representatives from the shareholders are members of the supervisory board – together with experts from universities, clinics, economy, other research institutes and from the HZI itself. The highest governing body of the HZI meets twice a year, it takes the major policy decisions and appoints the two directors. The scientific committee advices the supervisory board. The middle management of the centre is composed of the heads of academic departments, administrative units and staff units.
Dirk Heinz studied Chemistry and Biochemistry in Freiburg before he turned towards Structural Biology during his PhD work at the University of Basel. Following a postdoc period in the US, he returned to Freiburg for his habilitation. In 1998 he became a junior research group leader at the then German Research Centre of Biotechnology (GBF, now HZI) in Braunschweig, where he has headed the Department of Molecular Structural Biology between 2002 and 2013.
Dirk Heinz is Professor at the Technical University of Braunschweig and has promoted the field of structural biology for more than a decade as member of several national and international committees. Since 2009 he is a member of the European Molecular Biology Organization (EMBO).
After a one-year period as Acting Scientific Director, Dirk Heinz was appointed as Scientific Director of the HZI on 1st August 2011.